Anatomic Pathology Market Size, Share, Growth Analysis, By Product and Service(Consumables, Instruments, Services), By Application(Disease Diagnosis, Medical Research), By End-User(Hospitals, Clinics, Others), By Region - Industry Forecast 2024-2031

Anatomic Pathology Market size was valued at USD 35.21 billion in 2019 and is poised to grow from USD 37.71 billion in 2023 to USD 65.54 billion by 2031, growing at a CAGR of 7.3% in the forecast period (2024-2031).

anatomic pathology market is fairly consolidated with the presence of many well-known international and regional companies operating around the globe. Major players of the market are implementing on several business strategies including research & development, new product launches, collaborations, mergers, and partnerships to maintain their market share and expand their product portfolio to reach a wider consumer base. 'F. Hoffmann-La Roche AG', 'Danaher Corporation', 'Thermo Fisher Scientific Inc.', 'Becton, Dickinson and Company', 'Hologic, Inc.', 'Sakura Finetek Japan Co., Ltd.', 'Agilent Technologies, Inc.', 'Quest Diagnostics Incorporated', 'Laboratory Corporation of America Holdings', 'Bio-Rad Laboratories, Inc.', 'Merck KGaA', 'Siemens AG', 'Cell Signaling Technology, Inc.', 'PerkinElmer Inc.', 'Enzo Life Sciences, Inc.', 'Abcam plc', 'Epitomics, Inc.', 'Biocare Medical, LLC', 'Ventana Medical Systems, Inc.', 'Leica Biosystems Nussloch GmbH'

The increasing prevalence of various types of chronic diseases, as well as changes in consumer lifestyle and food habits, are the key major factors expected to drive the anatomic pathology market during the forecast period. According to our findings, the population of people over the age of 65 was around 727 million in 2020 and is expected to reach 1.5 billion by 2050. Since then, the tremendous growth in the population of the elderly is expected to create significant growth opportunities for the anatomic pathology market in the coming years.

Increasing usage of advanced pathology equipment like digital microscopes, staining systems, and gross imaging is creating lucrative growth opportunities for the market over the coming years. The features such as providing accuracy, specificity over the conventional techniques, and ease to use are enhancing the adoption of advanced anatomic pathology devices around the globe, thereby, the market is witnessing a strong growth in the coming years.

Globally, North America dominated the anatomic pathology market and accounted for the largest market share in 2021 and its set to continue this dominance throughout the forecast period. Increasing implementation of digital pathology, early adoption of advanced imaging tools, and rising consumer awareness regarding regular health screening are the few major factors likely to drive the growth of the market in the region over the coming years. In addition, presence of many well-known market players such as Pfizer Inc., Johnson & Johnson Pvt Ltd., and Abbott Laboratories in the region is also propelling the growth of the anatomic pathology market.

Anatomic Pathology Market size was valued at USD 35.21 billion in 2021 and is poised to grow from USD 37.71 billion in 2022 to USD 65.54 billion by 2030, growing at a CAGR of 7.3% in the forecast period (2023-2030).

anatomic pathology market is fairly consolidated with the presence of many well-known international and regional companies operating around the globe. Major players of the market are implementing on several business strategies including research & development, new product launches, collaborations, mergers, and partnerships to maintain their market share and expand their product portfolio to reach a wider consumer base. 'F. Hoffmann-La Roche AG', 'Danaher Corporation', 'Thermo Fisher Scientific Inc.', 'Becton, Dickinson and Company', 'Hologic, Inc.', 'Sakura Finetek Japan Co., Ltd.', 'Agilent Technologies, Inc.', 'Quest Diagnostics Incorporated', 'Laboratory Corporation of America Holdings', 'Bio-Rad Laboratories, Inc.', 'Merck KGaA', 'Siemens AG', 'Cell Signaling Technology, Inc.', 'PerkinElmer Inc.', 'Enzo Life Sciences, Inc.', 'Abcam plc', 'Epitomics, Inc.', 'Biocare Medical, LLC', 'Ventana Medical Systems, Inc.', 'Leica Biosystems Nussloch GmbH'

The increasing prevalence of various types of chronic diseases, as well as changes in consumer lifestyle and food habits, are the key major factors expected to drive the anatomic pathology market during the forecast period. According to our findings, the population of people over the age of 65 was around 727 million in 2020 and is expected to reach 1.5 billion by 2050. Since then, the tremendous growth in the population of the elderly is expected to create significant growth opportunities for the anatomic pathology market in the coming years.

Increasing usage of advanced pathology equipment like digital microscopes, staining systems, and gross imaging is creating lucrative growth opportunities for the market over the coming years. The features such as providing accuracy, specificity over the conventional techniques, and ease to use are enhancing the adoption of advanced anatomic pathology devices around the globe, thereby, the market is witnessing a strong growth in the coming years.

Globally, North America dominated the anatomic pathology market and accounted for the largest market share in 2021 and its set to continue this dominance throughout the forecast period. Increasing implementation of digital pathology, early adoption of advanced imaging tools, and rising consumer awareness regarding regular health screening are the few major factors likely to drive the growth of the market in the region over the coming years. In addition, presence of many well-known market players such as Pfizer Inc., Johnson & Johnson Pvt Ltd., and Abbott Laboratories in the region is also propelling the growth of the anatomic pathology market.